Showing results (381-390 of 397) with videos related to

Sort By:
Pageof 40
Circulation|December 15, 1996
Macrophages, smooth muscle cells, and tissue factor in unstable angina. Implications for cell-mediated thrombogenicity in acute coronary syndromesP R Moreno, V H Bernardi, J López-Cuéllar, et al.
Journal of Thrombosis and Haemostasis : JTH|November 10, 2012
Platelet function normalization after a prasugrel loading-dose: time-dependent effect of platelet supplementationM U Zafar, C Santos-Gallego, D A Vorchheimer, et al.
Cells|June 13, 2014
Unique Responses are Observed in Transient Receptor Potential Ankyrin 1 and Vanilloid 1 (TRPA1 and TRPV1) Co-Expressing CellsLaura R Sadofsky, Koti T Sreekrishna, Yakang Lin, et al.
Atherosclerosis|June 17, 2000
High resolution ex vivo magnetic resonance imaging of in situ coronary and aortic atherosclerotic plaque in a porcine modelS G Worthley, G Helft, V Fuster, et al.
The American Journal of Cardiology|May 15, 1983
Trial of combined warfarin plus dipyridamole or aspirin therapy in prosthetic heart valve replacement: danger of aspirin compared with dipyridamoleJ H Chesebro, V Fuster, L R Elveback, et al.
Journal of the American College of Cardiology|November 3, 2001
Blood thrombogenicity in type 2 diabetes mellitus patients is associated with glycemic controlJ I Osende, J J Badimon, V Fuster, et al.
Journal of the American College of Cardiology|July 14, 2001
Initiation of hormone replacement therapy after acute myocardial infarction is associated with more cardiac events during follow-upK P Alexander, L K Newby, A S Hellkamp, et al.
The American Journal of Cardiology|August 29, 2001
Comparison of two aspirin doses on ischemic stroke in post-myocardial infarction patients in the warfarin (Coumadin) Aspirin Reinfarction Study (CARS)C M O'Connor, W A Gattis, A S Hellkamp, et al.
Circulation|August 26, 1998
Hirudin reduces tissue factor expression in neointima after balloon injury in rabbit femoral and porcine coronary arteriesS D Gertz, J T Fallon, R Gallo, et al.
Clinical Pharmacology and Therapeutics|May 24, 2016
Exome sequencing of extreme clopidogrel response phenotypes identifies B4GALT2 as a determinant of on-treatment platelet reactivityS A Scott, J-P Collet, U Baber, et al.
Pageof 40